TCTR20210825007尚未招募1 期
Safety and Efficacy of Chula High Flow Nasal Cannula
/A0 个研究点目标入组 15 人开始时间: 2021年8月25日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 65 Years（—）
- 性别
- All
入选标准
- •Phase 1: Healthy subjects (N=5)
- •Phase 2: COVID-19 pneumonia with respiratory failure (PF ratio 150-300 or SpO2 <90-94% while using conventional oxygen therapy) for at least 2 hours or met other criteria to use HFNC (N=10)
排除标准
- •Phase 1: 1. underlying significant cardiopulmonary disease
- •2. unable to communicate
- •Phase 2: 1. signs of respiratory failure (RR>40) or use accessory muscles
- •2. met criteria for intubation including PF ratio<50, unable to protect airway, mental status change, unstable hemodynamic, reduction in glasgow coma scale<10
研究者
相似试验
尚未招募
1 期
To compare effectiveness of high flow nasal cannula as a method for weaning compared to conventional weaning in mechanically ventilated patients in critical care unitCTRI/2022/06/043187King George medical college
已完成
不适用
sefulness of high-flow nasal cannula therapy among patients undergoing cardiothoracic surgeryJPRN-UMIN000023377Department of Anesthesiology, Kyorin University School of Medicine150
已完成
不适用
sefulness of High-Flow Nasal Cannula for Prevention of Hypoxemia during bronchoscopymediastinal lymphadenopathyJPRN-UMIN000029967agoya City University Graduate School of Medical Sciences15
尚未招募
3 期
A study to see if a new breathing device called the indigenous HFNC to give oxygen and humidification help people with acute breathing problems more effectively than the standard HFNC deviceCTRI/2023/08/056098Amrita Institute of Medical Sciences
尚未招募
不适用
we are evaluating the efficacy of high flow nasal cannula during fibre optic intubation under general anesthesiaCTRI/2021/04/032516dr ram manohar lohia institute of medical sciences